Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,309-1,320 of 4,306
Behavioral study icon
CompletedNCT04949542

Bolster: Caregiver App to Reduce Duration of Untreated Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Seattle
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 80 Years
Countries
United States
Sponsor
University of Washington
Condition
Schizophrenia
Other study type icon
Active Not RecruitingNCT06453174

CLinical Utility of Early Intervention Including the 5-Step Precision Medicine (5SPM) Method in First-episode Psychosis: The CLUMP Project

This summary needs review. Please check the official study record and contact the research team for details.

In Salamanca
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 12 Years to 35 Years
Countries
Spain
Sponsor
Instituto de Investigación Biomédica de Salamanca
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT02102113

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02009826

Psychosis-Associated Neuroinflammation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Boechout
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 40 Years
Countries
Belgium
Sponsor
Universiteit Antwerpen
Condition
Schizophrenia
Behavioral study icon
Active Not RecruitingNCT06251908

REWRITALIZE Your Recovery - Evaluation of a Creative Writing Group Intervention

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Rønne
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, PTSD, ...BehavioralOver 18 Years
Countries
Denmark
Sponsor
Amager Hospital
Condition
Schizophrenia, PTSD, ...
Drug study icon
Active Not RecruitingNCT05333003

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02069925

STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 16 Years to 35 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT04140773

The Effect of D-serine as add-on Therapy in Recent-onset Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Basel
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Switzerland
Sponsor
Dragos Inta
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.